Press releases & Latest news
Isofol Announces Presentation on the Global Phase 3 Study of arfolitixorin in Metastatic Colorectal Cancer at 2019 ESMO Congress
GOTHENBURG, Sweden, September 29, 2019 - Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced a poster presentation…
Published abstract at ESMO
Published abstract at ESMO “Open label phase III study of arfolitixorin vs leucovorin in mFOLFOX-6 for first-line treatment of metastatic…
Isofol Announces that an Abstract has been Accepted for Presentation at the 2019 ESMO Congress
GOTHENBURG, Sweden, September 12, 2019 - Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced that an abstract…
Upcoming Events
- Financial report - third quarter, 2019
November 13, 2019 - November 13, 2019 - RedEye: Life Science Day, Stockholm, Sweden
November 19, 2019 - November 19, 2019 - DNB: Nordic-American Life Science Conference 2019, New York, USA
December 04, 2019 - November 05, 2019 - JP Morgan, Biotech Showcase, San Francisco, USA
January 13, 2020 - January 15, 2020